Fig. 1

The expression of LANCL2 in stomach adenocarcinoma (STAD) and pan-cancer. (A) The TIMER2.0 database showed differential expression of LANCL2 in pan-cancer. (B) The expression of LANCL2 in STAD and normal gastric tissues were analyzed by the TCGA-STAD cohort. (C) The expression of LANCL2 in STAD and normal gastric tissues were analyzed by the TCGA-STAD cohort and GTEx database. (D) The expression of LANCL2 in STAD and normal gastric tissues were analyzed by paired samples from the TCGA-STAD cohort. (E) The expression of LANCL2 in STAD and normal gastric tissues were analyzed by the GSE29272 dataset. (F) The expression of LANCL2 in STAD and normal gastric tissues were analyzed by the GSE66229 dataset. (G) The expression of LANCL2 mRNA in GC cells by qRT-PCR. (H) The expression of LANCL2 mRNA in 53 paired gastric cancer tissues and paraneoplastic tissues by qRT-PCR. (I) The expression of LANCL2 protein in gastric cancer and normal tissues by the HPA database. (^*P < 0.05, ^**P < 0.01, ^***P < 0.001, ^****P < 0.0001).